Skip to content
Obsidio
  • Technology
  • Applications
  • About Us
  • Press
  • Publications
  • Contact

Press

Obsidio, Inc. is selected as a 2020 Rosenman Innovator!

Obsidio announces the formation of clinical advisory board

Obsidio is selected to participate in the TMCx09 Medical Device Accelerator Program

Obsidio Raises Seed Round Led by Good Growth Capital to Develop Universal Gel Embolic Material

  • Previous Page
  • 1
  • 2

Sign up for Obsidio Updates

  • Technology
  • Applications
  • About Us
  • Press
  • Publications
Obsidio

© Copyright 2022 Obsidio Privacy Policy Web Design by Beam & Hinge

  • Twitter
  • Linked-in

Obsidio's portfolio of products is under development and does not have marketing clearance or approval in any market at this time. For investigational use only. Not available for sale.